Collection 17 April 2020

Advances in Schizophrenia research

This collection brings together outstanding papers from Molecular Psychiatry to create a summary of recent advances in schizophrenia research, a major psychiatric disorder of immense public health relevance.

Part 1

Advances in schizophrenia research: first special issue, 2020
- Julio Licinio
Editorial14 Apr 2020 Molecular Psychiatry
The role of the retinoids in schizophrenia: genomic and clinical perspectives
- William R. Reay
- Murray J. Cairns
Review ArticleOpen Access30 Oct 2019 Molecular Psychiatry
Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtype
- William R. Reay
- Joshua R. Atkins
- Murray J. Cairns
ArticleOpen Access7 Dec 2018 Molecular Psychiatry
Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments
- Francesco Petrelli
- Glenn Dallérac
- Paola Bezzi
ArticleOpen Access20 Aug 2018 Molecular Psychiatry
mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia
- Hoau-Yan Wang
- Mathew L. MacDonald
- Chang-Gyu Hahn
Article13 Sep 2018 Molecular Psychiatry
Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation
- Helen Q. Cai
- Vibeke S. Catts
- Cynthia Shannon Weickert
ArticleOpen Access13 Sep 2018 Molecular Psychiatry
Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects
- Madeline R. Scott
- James H. Meador-Woodruff
Article25 Jan 2019 Molecular Psychiatry
Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain
- Eugenia Radulescu
- Andrew E. Jaffe
- Daniel R. Weinberger
Article26 Nov 2018 Molecular Psychiatry
NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia
- Oded Bergman
- Rachel Karry
- Dorit Ben-Shachar
Article10 Dec 2018 Molecular Psychiatry
Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia
- Boris Chaumette
- Vladimir Ferrafiat
- Guy A. Rouleau
Article12 Jun 2018 Molecular Psychiatry
Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19)
- Liang Ma
- Stephen A. Semick
- Richard E. Straub
Article11 Jan 2019 Molecular Psychiatry
Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence
- Olav B Smeland
- Shahram Bahrami
- Ole A Andreassen
Article4 Jan 2019 Molecular Psychiatry
Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank
- Anthony Warland
- Kimberley M. Kendall
- Xavier Caseras
ArticleOpen Access24 Jan 2019 Molecular Psychiatry
Baseline brain structural and functional predictors of clinical outcome in the early course of schizophrenia
- Gaelle E. Doucet
- Dominik A. Moser
- Sophia Frangou
Article3 Oct 2018 Molecular Psychiatry
Glutathione and glutamate in schizophrenia: a 7T MRS study
- Jyothika Kumar
- Elizabeth B. Liddle
- Peter F. Liddle
ArticleOpen Access22 Jun 2018 Molecular Psychiatry
White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals
- Daisuke Koshiyama
- Masaki Fukunaga
- COCORO
ArticleOpen Access29 Nov 2019 Molecular Psychiatry
Prevention of schizophrenia deficits via non-invasive adolescent frontal cortex stimulation in rats
- Ravit Hadar
- Rebecca Winter
- Christine Winter
Article28 Jan 2019 Molecular Psychiatry
Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity
- Bo Cao
- Raymond Y. Cho
- Xiang Yang Zhang
Article19 Jun 2018 Molecular Psychiatry

Advances in Schizophrenia research

Part 1

Advances in schizophrenia research: first special issue, 2020

The role of the retinoids in schizophrenia: genomic and clinical perspectives

Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtype

Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments

mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia

Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation

Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects

Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain

NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia

Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia

Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19)

Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence

Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank

Baseline brain structural and functional predictors of clinical outcome in the early course of schizophrenia

Glutathione and glutamate in schizophrenia: a 7T MRS study

White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals

Prevention of schizophrenia deficits via non-invasive adolescent frontal cortex stimulation in rats

Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity

Search

Quick links